Heart Rhythm 2026: Electrophysiologist Mina Chung Discusses CPR, PFA and Much More

Why It Matters

The initiatives aim to improve survival from sudden cardiac arrest, ensure safety of rapidly adopted PFA technology, and reduce procedural costs, directly impacting patient outcomes and healthcare economics. Securing federal support for CPR education and easing reimbursement hurdles will shape the future landscape of electrophysiology care.

Key Takeaways

• HRS task force pushes CPR/AED education in high schools via app partnerships
• New PFA registry aims to capture long‑term safety data with AI‑driven entry
• CMS approves atrial fibrillation ablations in ambulatory surgical centers, cutting costs
• HRS research network links EP investigators, industry and AI tools for collaboration
• Advocacy focuses on funding HEARTS Act, easing prior authorizations and remote monitoring

Pulse Analysis

The push to embed CPR and AED training in high schools reflects a broader public‑health strategy to address the roughly 350,000 sudden cardiac arrests that occur annually in the United States. By partnering with digital‑health firms, HRS hopes to transform a one‑time class into an ongoing, app‑driven learning loop, improving skill retention and creating a generation more prepared to intervene. Funding the HEARTS Act would provide the federal resources needed to scale these programs nationwide, potentially raising survival rates well above the current 10 %.

Pulsed field ablation has quickly become a preferred therapy for atrial fibrillation due to its non‑thermal energy delivery and reduced collateral damage. However, as patient volumes surge, rare complications are emerging that were not evident in early trials. HRS’s new PFA registry, bolstered by AI‑assisted data capture, promises real‑time safety monitoring and long‑term outcome tracking, filling a critical gap left by traditional FDA post‑market surveillance that often stops after a few years. The registry’s “super” data platform could inform best‑practice guidelines and accelerate mitigation strategies across the electrophysiology community.

The CMS decision to allow atrial fibrillation ablations in ambulatory surgical centers marks a decisive shift toward decentralizing cardiac care. Performing these procedures outside hospitals can lower costs by up to 30 % while maintaining comparable clinical outcomes for appropriately selected patients. Complementing this cost‑efficiency drive, HRS’s newly launched research network connects academic investigators, industry partners, and AI innovators, fostering collaborative studies that can streamline device surveillance and accelerate therapeutic advances. Together, these policy moves and collaborative frameworks aim to enhance patient access, reduce expenditures, and sustain innovation in the rapidly evolving EP landscape.